Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
GC Biopharma Corp (006280 KS)
Watchlist
115
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung C&T
•
16 Oct 2017 14:58
Samsung Restructuring Update - Local Institutions Are Scooping Up Samsung C&T
Check this. The stock that ranked top in the local institutions' top 10 net buying stock list for last week (Oct 10-13) is Samsung C&T Corp...
Sanghyun Park
Follow
472 Views
Share
bullish
•
Eubiologics
•
13 Jan 2017 00:29
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
Sanghyun Park
Follow
629 Views
Share
bullish
•
Eubiologics
•
10 Jan 2017 16:02
Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level
*Â In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...
Sanghyun Park
Follow
355 Views
Share
bullish
•
Eubiologics
•
08 Jan 2017 02:20
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
Sanghyun Park
Follow
537 Views
Share
bullish
•
Yuhan Corp
•
27 Dec 2016 15:50
Yuhan Corp: (Part I) - Oversold on Hanmi Pharma Scares
Why Look atYuhan Corp?Yuhan Corp shares are quite interesting at current levels. It is currently trading at 214,000 won, which is down 38% (A...
Douglas Kim
Follow
1.4k Views
Share
First
Previous
12
13
14
15
16
17
18
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x